Hypersensitivity pneumonitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 126: Line 126:
!DLCco
!DLCco
!
!
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |Hypersensitivity Pneumonitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* History of [[allergen]] exposure
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Diffuse fine bibasilar [[crackles]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Constitutional symptoms
** [[Weight loss]]
** Anorexia
** Muscle weakness
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Neutrophilia
* Elevated [[ESR]]
* Elevated [[CRP]]
* Elevated [[immunoglobulin]]
* No peripheral blood [[eosinophilia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Poorly defined micronodular or diffuse interstitial pattern
* In chronic form
** Fibrosis
** Loss of lung volume
** Coarse linear opacities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Ground-glass opacities '''or'''
* Diffusely increased radiodensities
* Diffuse micronodules
* Focal air trapping
* Mosaic perfusion
* Occasionaly thin-walled cysts
* Mild fibrotic changes 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Clinical diagnosis
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Acute respiratory distress syndrome|Acute Respiratory Distress Syndrome]] ([[Acute respiratory distress syndrome|ARDS]])
| colspan="2" |[[Acute respiratory distress syndrome|Acute Respiratory Distress Syndrome]] ([[Acute respiratory distress syndrome|ARDS]])
Line 228: Line 270:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*N/A
*N/A
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Hypersensitivity pneumonitis|Hypersensitivity Pneumonitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* History of [[allergen]] exposure
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Diffuse fine bibasilar [[crackles]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Constitutional symptoms
** [[Weight loss]]
** Anorexia
** Muscle weakness
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Neutrophilia
* Elevated [[ESR]]
* Elevated [[CRP]]
* Elevated [[immunoglobulin]]
* No peripheral blood [[eosinophilia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Poorly defined micronodular or diffuse interstitial pattern
* In chronic form
** Fibrosis
** Loss of lung volume
** Coarse linear opacities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Ground-glass opacities '''or'''
* Diffusely increased radiodensities
* Diffuse micronodules
* Focal air trapping
* Mosaic perfusion
* Occasionaly thin-walled cysts
* Mild fibrotic changes 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Clinical diagnosis
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |[[Occupational lung disease|Pneumoconiosis]]<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref>
| rowspan="4" |[[Occupational lung disease|Pneumoconiosis]]<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref>
Line 514: Line 514:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Wheezing]]
* [[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Polycythemia|Increased hematocrit]]
* [[Polycythemia|Increased hematocrit]]

Revision as of 18:46, 1 March 2018

Hypersensitivity pneumonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypersensitivity pneumonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hypersensitivity pneumonitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypersensitivity pneumonitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypersensitivity pneumonitis differential diagnosis

CDC on Hypersensitivity pneumonitis differential diagnosis

Hypersensitivity pneumonitis differential diagnosis in the news

Blogs on Hypersensitivity pneumonitis differential diagnosis

Directions to Hospitals Treating Hypersensitivity pneumonitis

Risk calculators and risk factors for Hypersensitivity pneumonitis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The differential diagnosis of hypersensitivity pneumonitis is, primarily, a group of diseases known as idiopathic interstitial pneumonias. This group of diseases includes idiopathic pulmonary fibrosis (IPF) (which manifests histologically as usual interstitial pneumonia (UIP)), idiopathic non-specific interstitial pneumonia (NSIP) and cryptogenic organizing pneumonia, among others. There are several important clinical syndromes that occur as a result of inhalation of organic agents but are not true forms of Hypersensitivity Pneumonitis.

Differential Diagnosis

Other diseases that are secondary to inhalation of organic agents but are not true forms of HP are as follows:

  1. Inhalation fever: Patients present with fever, chills, headache, and myalgias however there are not pulmonary findings (although mild dyspnea may occur). Onset is 4-8 hours following exposure. There are no long-term sequelae occur.
  2. Organic dust toxic syndrome: This syndrome is the result of exposure to bioaerosols contaminated with toxin-producing fungi (mycotoxins). Patients present with fever, chills, and myalgias 4-6 hours after exposure. In contrast to inhalation fever, the chest X ray may show diffuse opacities. Bronchiolitis or diffuse alveolar damage may be present on lung biopsy specimens. This is not a true form of HP because no prior sensitization is required.
  3. Chronic bronchitis: This can result from chronic obstructive pulmonary disease, which is the most common respiratory syndrome among agricultural workers. The prevalence of chronic bronchitis is much higher at 10%, compared with 1.4% for HP.
  4. Exposure to aerosolized Mycobacterium avium complex (MAC): A hypersensitivity pneumonitis like syndrome has been described in patients exposed to aerosolized Mycobacterium avium complex (MAC). Hot tub lung is a term used to describe these hypersensitivity pneumonitis-like cases because they have generally been associated with hot tub use. The syndrome has been linked to the high levels of infectious aerosols containing MAC organisms found in the water. Whether this syndrome represents a true MAC infection or classic HP remains controversial (Marras, 2005).


By frequency of Interstitial Lung Diseases (Xaubet, 2004):

  1. Idiopathic pulmonary fibrosis (38.6%)
  2. Sarcoidosis (14.9%)
  3. Cryptogenic organizing pneumonia (10.4%)
  4. Interstitial lung disease associated with collagen vascular diseases (9.9%)
  5. Hypersensitivity Pneumonitis (HP) (6.6%)
  6. Unclassified (5.1%)

In alphabetical order:

Restrictive lung disease must be differentiated from other diseases that cause dyspnea, cough, hemoptysis, and fever such as ARDS, bronchitis, hypersensitivity pneumonitis, pneumoconiosis.

Pulmonary Function Test Obstructive Lung Disease Restrictive Lung Disease
TLC
RV
FVC
FEV1 ↓↓
FEV1/FVC N to
MVV

Approach to Lung Disorders

 
 
 
 
 
 
 
 
 
 
 
 
 
Spirometry
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal to high FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obstructive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
Restrictive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bronchodilator therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased FEV1
 
 
 
 
 
 
 
No change in FEV1
 
 
 
Normal DLCO
 
 
 
 
 
 
 
Decreased DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asthma
 
 
 
 
 
 
 
COPD
 
 
 
Chest wall disorders
 
 
 
 
 
 
 
Interstitial Lung Disease
 
 


Spirometry Findings in Various Lung Conditions

Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])
Disease Clinical manifestations Diagnosis
Symptoms Physical exam Lab findings Imaging Gold standard
Cough Dyspnea Hemoptysis Fever History/Exposure Cyanosis Clubbing JVD Peripheral edema Auscultation Other prominent findings CXR CT DLCco
Hypersensitivity Pneumonitis + + - + - + - -
  • Constitutional symptoms
  • Poorly defined micronodular or diffuse interstitial pattern
  • In chronic form
    • Fibrosis
    • Loss of lung volume
    • Coarse linear opacities
  • Ground-glass opacities or
  • Diffusely increased radiodensities
  • Diffuse micronodules
  • Focal air trapping
  • Mosaic perfusion
  • Occasionaly thin-walled cysts
  • Mild fibrotic changes 
  • Clinical diagnosis
Acute Respiratory Distress Syndrome (ARDS) - + - - + - - -
  • Bilateral pulmonary infiltrates
    • Initially patchy peripheral
    • Later diffuse bilateral
  • Ground glass
  • Frank alveolar infiltrate
  • Bronchial dilatation within areas of ground-glass opacification
  • PaO2 / FiO2 <300
Bronchitis Acute + - +/- + - - - - -
  • Diffuse wheezes
  • High-pitched continuous sounds
  • The use of accessory muscles 
  • Prolonged expiration
  • Rhonchi
  • Rales
  • N/A
  • Normal
  • N/A
-
  • Clinical diagnosis
Chronic + + - -
  • A positive history of chronic productive cough 
  • Shortness of breath 
+ - + +
  • Prolonged expiration; wheezing
  • Diffusely decreased breath sound
  • Coarse crackles with inspiration
  • Coarse rhonchi
  • N/A
  • Radiolucency
  • Diaphragmatic flattening due to hyperinflation
  • Increased retrosternal airspace on the lateral radiograph
  • N/A
  • N/A
Pneumoconiosis[1] SIlicosis[2][3] + + +/- -
  • Occupational history
    • Sandblasting
    • Bystanders
    • Quartzite miller
    • Tunnel workers
    • Silica flour workers
    • Workers in the scouring powder industry
+ + + -
  • Small round opacities
    • Symmetrically distributed
    • Upper-zone predominance
  • Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
  • Nodular changes in lung parenchyma
  • Progressive massive fibrosis
  • Bullae, emphysema
  • Pleural, mediastinal, and hilar changes
Asbestosis
  • Shipyard workers
  • Pipe fitting
  • Insulators
  • Predilection to lower lobes
  • Fine and coarse linear, peripheral, reticular opacities
  • Subpleural linear opacities seen parallel to the pleura
  • Basilar lung fibrosis
  • Peribronchiolar, intralobular, and interlobular septal fibrosis;
  • Honeycombing
  • Pleural plaques.
Berylliosis 
  • Electronic manufactures
-
  • Hilar adenopathy
  • Increased interstitial markings.
  • Ground glass opacification
  • Parenchymal nodules
  • Septal lines
Byssinosis 
  • Cotton wool workers
  • Diffuse air-space consolidation
  • Pulmonary fibrosis with honeycombing
  • Peri bronchovascular distribution of nodules
  • Ground-glass attenuations
Sarcoidosis + + + + - - - -
  • Usually normal
  • Occasional crackles
  • Bilateral hilar lymphadenopathy
  • High-resolution CT (HRCT) scanning of the chest may identify
    • Active alveolitis
    • Fibrosis
Pleural Effusion + + +/- +/- Transudate

Exudate

+/- +/- +/- +/-
  • Peripheral edema, distended neck veins, and S3 gallop suggest congestive heart failure.
  • Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome.
  • Cutaneous changes and ascites suggest liver disease.
  • Lymphadenopathy or a palpable mass suggests malignancy.
Supine
  • Blunting of the costophrenic angle
  • Homogenous increase in density spread over the lower lung fields

Lateral decubitus

  • Free flowing effusion as layers
  • Thickened pleura
  • Mild effusions can aslo be detected
Interstitial (Nonidiopathic) Pulmonary Fibrosis + ++ + - + + + +
  • Increased A-a gradient
  • Elevated ESR
  • Serologic testing for ANA, RF, ANCA & ASCA may be positive
  •  Reticular and/or nodular opacities
  • Honeycomb appearance (late finding)
  • Bilateral reticular and nodular interstitial infiltrates
Video-assisted thoracoscopic lung biopsy
Lymphocytic Interstitial Pneumonia[4] + + + + - + - -
  • Increased A-a gradient
  • Polyclonal hypergammaglobulinemia
  • Increased LDH
  • Bibasilar interstitial or micronodular infiltrates
  • Determines the degree of fibrosis
  • Cysts (characterstic)
N Open lung biopsy
Obesity[5][6] + + - - - - - + -
  • X ray findings are often limited due to body habitus
  • CT findings are variable and depends upon severity of obesity
N Clinical
Pulmonary Eosinophilia[7] + + + + Infections + - + +
  • Increased A-a gradient
  • Interstitial or diffuse nodular densities
  • Determines extent and distribution of the disease
  • Interstitial infiltrates
  • Cysts and nodules
Biopsy of lesion (skin or lung)
Neuromuscular disease Scoliosis - + - -
  • Postural abnormality
- - - -
  • In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
  • Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
  • N/A
N
  • Clinical
  • Radiographs
Muscular dystrophy - + - -
  • Proximal muscle weakness
- - - -
  • N/A
  • N/A
N
ALS - + - -
  • Muscle weakness
  • Neurological deficit
- - - -
  • Symptoms begin with limb involvement diue to muscle weakness and atrophy. 
  • Cognitive or behavioral dysfunction
  • Sensory nerves and the autonomic nervous system are generally unaffected
N/A Not significant/diagnostic Not significant/diagnostic -
Myasthenia gravis - + - + H/O of difficulty getting up from chair - - - -
  • Extraocular, bulbar, or proximal limb muscles.
  • Breathing as rapid and shallow
  • Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation.
  • Anti–acetylcholine receptor (AChR) antibody (Ab) test +
  • Thymoma as an anterior mediastinal mass.
  • Thymoma as an anterior mediastinal mass.
N

References

  1. Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ (1998). "Idiopathic pulmonary fibrosis: predicting response to therapy and survival". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1063–72. doi:10.1164/ajrccm.157.4.9703022. PMID 9563720.
  2. du Bois RM (2006). "Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis". Clin. Chest Med. 27 (1 Suppl 1): S17–25, v–vi. doi:10.1016/j.ccm.2005.08.001. PMID 16545629.
  3. Neghab M, Mohraz MH, Hassanzadeh J (2011). "Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust". J Occup Health. 53 (6): 432–8. PMID 21996929.
  4. Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H (1999). "Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT". AJR Am J Roentgenol. 173 (1): 71–4. doi:10.2214/ajr.173.1.10397102. PMID 10397102.
  5. Zammit C, Liddicoat H, Moonsie I, Makker H (2010). "Obesity and respiratory diseases". Int J Gen Med. 3: 335–43. doi:10.2147/IJGM.S11926. PMC 2990395. PMID 21116339.
  6. O’Neill, Donal (2015). "Measuring obesity in the absence of a gold standard". Economics & Human Biology. 17: 116–128. doi:10.1016/j.ehb.2015.02.002. ISSN 1570-677X.
  7. de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML (2009). "Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma". Am. J. Trop. Med. Hyg. 81 (3): 424–7. PMID 19706907.


Template:WikiDoc Sources